Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery
Unit 1 of NANBIOSIS, Protein Production Platform (PPP) and the Nanobiotechnology research group of CIBER-BBN in collaboration with the Universidade Estadual de Campinas and the Universidade de São Paulo have recently published, in the European Journal of Pharmaceutical Sciences, the results of the research devoted to the improvement of protein-only based nanoconjugates for gene therapy. The evaluated gene-therapy vehicle prototype displayed a similar transfection efficiency to that of the commercial vector LipofectamineTM 2000.
Article of reference:
